Companies
Every company with a round in the feed.
| Company | Rounds | Raised | Latest round |
|---|---|---|---|
Skild AI Skild develops AI technology for robotics, enabling machines to perform physical tasks in real-world environments. | 2 | $1.7B | Series C 2026-01-14 |
Onebrief Onebrief is collaboration and AI-powered workflow software designed specifically for military staffs. | 4 | $270M | Series D 2026-01-13 |
| 5 |
| $290.9M |
| Series D 2026-01-13 |
Sukino Sukino provides post-hospital rehabilitation services, including medical rehabilitation therapies, home healthcare, and elder care, catering to patients recovering after surgery or serious health issues. | 1 | $31M | Series B 2026-01-13 |
Defense Unicorns They provide secure software delivery platforms designed specifically for military systems, aimed at government and industry customers. | 1 | $136M | Series B 2026-01-13 |
JetZero JetZero designs and manufactures innovative all-wing aircraft focusing on efficiency and passenger experience for airlines. | 1 | $175M | Series B 2026-01-13 |
Mirador Therapeutics Mirador Therapeutics focuses on developing precision medicines for immune-mediated inflammatory and fibrotic diseases. | 2 | $650M | Series B 2026-01-12 |
Harmattan AI Harmattan sells autonomous military capabilities, including air defense systems and reconnaissance technology, primarily to defense organizations. | 1 | $200M | Series B 2026-01-12 |
Kinaset Therapeutics Developing inhaled therapeutics for respiratory diseases, specifically targeting severe asthma patients. | 2 | $143M | Series B 2026-01-10 |
Rain Stablecoin payments platform for enterprise | 3 | $332.5M | Series C 2026-01-09 |
Lambda Cloud-computing company | 6 | $2.4B | Funding round 2026-01-09 |
EpiBiologics They develop bispecific antibodies designed to selectively degrade disease-causing extracellular proteins. | 2 | $157M | Series B 2026-01-08 |
Diagonal Therapeutics They develop innovative clustering antibodies for the treatment of genetic diseases. | 2 | $253M | Series B 2026-01-08 |
| 1 | $1.3M | Pre-A 2026-01-07 |
Swap Swap-commerce offers e-commerce solutions, including a platform for guided shopping and fulfillment services to businesses looking to enhance their online sales. | 3 | $149M | Series C 2026-01-07 |
Rakuten Medical Rakuten Medical develops cancer therapies based on the Alluminox® platform, aimed at treating various cancers. | 6 | $769M | Series F 2026-01-07 |
Soley Therapeutics Soley Therapeutics is a biotech company that discovers and develops novel medicines by leveraging the sensing capabilities of human cells. | 1 | $200M | Series C 2026-01-07 |
Even Healthcare A healthcare startup aiming to change hospital economics in India | 3 | $65M | Funding round 2026-01-06 |
SpaceXAI The company sells AI-driven APIs and solutions focused on text, voice, and image processing for developers and businesses. | 3 | $32B | Series D+ 2026-01-06 |
Cambium Advanced materials for industries like defense, aerospace, and energy, targeted at manufacturers and engineering teams. | 2 | $119M | Series B 2026-01-05 |
RayNeo RayNeo sells augmented reality (AR) and artificial intelligence (AI) glasses designed for entertainment and productivity. | 1 | $143.2M | Funding round 2026-01-05 |
Zomint Zomint provides wealth management services including mutual funds, global investing, and precious metal investments, primarily targeting individual investors. | 1 | $3.7M | Seed 2026-01-01 |
Dp AI-driven tools and services for scientific research and discovery, catering to scientists and research organizations. | 1 | $114.1M | Series C 2025-12-24 |
Nirvana Insurance Nirvanatech provides AI-powered commercial insurance solutions, particularly tailored for fleet management. | 3 | $202M | Series D 2025-12-18 |
Neural Concept An intelligence platform that provides AI-powered solutions for engineering teams to enhance product design and development processes. | 3 | $136.1M | Series C 2025-12-18 |
Syremis Therapeutics Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. | 1 | $165M | Series A 2025-12-18 |
Mythic Mythic sells innovative AI chips designed for high energy efficiency and performance in various applications including automotive and robotics. | 5 | $278M | Funding round 2025-12-17 |
MoEngage Agentic Customer Engagement Platform | 6 | $421M | Series D+ 2025-12-17 |
SkillCorner The leading provider of AI-driven sports tracking and contextual performance data | 1 | $60M | Growth 2025-12-17 |
Radiant Radiant Nuclear sells nuclear microreactors designed for commercial and government customers, providing independent energy solutions. | 4 | $506.2M | Funding round 2025-12-17 |
Imprint Imprint sells co-branded financial products such as credit cards, deposit accounts, and installment loans, targeted at businesses looking to enhance customer engagement and spending. | 3 | $263M | Series D 2025-12-17 |
Addition Therapeutics Additiontx sells genetic medicines using their PRINT technology to address severe lifelong diseases in patients. | 1 | $100M | Series A 2025-12-17 |
RedotPay RedotPay Crypto Card: Fast, Low-Fee Global Payments. | 3 | $194M | Series B 2025-12-16 |
Last Energy Last Energy provides a full-service model for deploying nuclear power plants, offering customers reliable and affordable energy without the need for them to develop, finance, or operate the facilities themselves. | 2 | $140M | Series C 2025-12-16 |
Adaptive Security Adaptive Security offers unified security awareness training, email security, and AI governance tools designed to protect organizations against cyber threats, especially those leveraging AI technology. | 2 | $124M | Series B 2025-12-16 |
Ambros Therapeutics Innovative medicines for diseases with high unmet medical need, specifically targeting Complex Regional Pain Syndrome Type 1. | 1 | $125M | Series A 2025-12-16 |
Premialab Premialab offers a platform that provides advanced quantitative data solutions for investment management, targeting asset owners, asset managers, and consultants. | 1 | $220M | Growth 2025-12-16 |
EDT A consumer technology brand | 1 | $1.4M | Pre-seed 2025-12-16 |
Octane Instant financing solutions for motorcycles, ATVs, mowers, and more for consumers. | 3 | $202M | Series F 2025-12-15 |
Port Port provides a platform for organizations to build, govern, and operate agentic software development lifecycles (SDLC) utilizing AI technologies. | 4 | $160M | Series C 2025-12-11 |
Harness Harness is a unified AI software delivery platform to manage the SDLC using purpose-built AI agents. | 5 | $610M | Series E 2025-12-11 |
Kredivo Kredivo Group provides digital financial services, including instant credit financing for ecommerce purchases and personal loans, primarily targeting Indonesian consumers and merchants. | 5 | $490M | Funding round 2025-12-11 |
Impulse Dynamics Impulse Dynamics sells the Optimizer® Smart System, a medical device delivering cardiac contractility modulation therapy for patients with heart failure. | 6 | $509.3M | Funding round 2025-12-10 |
Fervo Energy Fervo Energy develops next-generation geothermal projects to deliver 24/7 carbon-free energy. | 4 | $854M | Series E 2025-12-10 |
Bobyard AI takeoff and estimating for trade contractors | 1 | $35M | Series A 2025-12-10 |
Green Energy Origin (GEO) Geosi sells advanced battery materials and specialty chemicals for electric vehicles and other industries transitioning to green energy. | 1 | $110M | Series B 2025-12-10 |
fal Fal sells a generative media platform for developers that includes models for image, video, audio, and associated infrastructure. | 4 | $328M | Series D 2025-12-09 |
D3 Bio D3 Bio develops innovative and efficacious medicines focused on oncology and immunology, targeting unmet patient needs. | 3 | $370M | Series B 2025-12-09 |
Unconventional AI An AI company focused on developing efficient computing solutions that integrate biology-scale principles into artificial intelligence processes. | 1 | $475M | Seed 2025-12-09 |
Boom Supersonic Boom Supersonic designs and manufactures supersonic airliners and natural gas turbines for the aviation and energy markets. | 7 | $638M | Series B 2025-12-09 |